PON2 and melanoma: In the light of these results, the evaluation of PON2 as a molecular target for this cutaneous neoplasm deserved to be carried out, focusing on exploring the ability of the enzyme to participate to the mechanisms involved in melanoma cell sensitivity to chemotherapy.